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Abstract 
There is considerable interest in transcatheter prosthetic valve treatment for mitral 
valve disease in high-risk individuals. Although the presence of mitral annular 
calcium (MAC) may provide an anchoring zone for such devices, results to date have 
been modest with reported technical failure rates approaching 30% in specialist 
centres. This in part relates to the risk of left ventricular outflow tract obstruction and 
device dislodgment but also to the lack of specific imaging guidelines to plan for such 
procedures. We present the use of finite element analysis and computer simulation 
based on cardiac CT in three patients with severe MAC in whom transcatheter 
devices were considered. In the first two cases, the computer simulations were 
performed after the clinical procedure and were concordant with the clinical outcome. 
For the third case, computer simulation was performed prior to the clinical procedure. 
This indicated unsuitability for transcatheter device deployment and a subsequent 
medical management was adopted. Overall, our initial results suggest that computer 
simulation may have the potential to improve patient selection for transcatheter mitral 
valve replacement in the presence of significant MAC.  
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Introduction 
In mitral valve annulus calcification (MAC), the fibrous integrity of the annulus 
becomes gradually replaced by calcium.1 MAC may be associated with mitral valve 
stenosis (MS) or regurgitation (MR). Although in such instances conventional mitral 
valve replacement (MVR) surgery remains the first line treatment, the presence of 
MAC may require surgical debridement which can result in ventricular or 
atrioventricular groove rupture and damage to the adjacent coronary arteries.  
 
Given these challenges, there has been considerable interest in the use of less 
invasive transcatheter therapies for mitral valve disease, using both self-expanding 
and balloon inflatable transcatheter aortic valves.2-4 Although these have shown 
some early promise, complication rates remain high.5 The principal aim of the current 
study was to determine whether computational modeling of transcatheter mitral valve  
replacement (TMVR) with aortic prostheses in patients with significant MAC has the 
potential to a improve patient selection and reduce complication rates.  
 
 
Methods 
Patients 
In this study, 3 patients with MAC were considered for a TMVR procedure using 
aortic prostheses in the mitral position. All patients underwent retrospectively ECG-
gated multiphase cardiac CT scans covering the entire cardiac cycle and computer 
simulations to predict the effects of device deployment within the mitral position with 
respect to conformity to the native mitral valve annulus and the likelihood of left 
ventricular outflow tract obstruction (LVOTO).  
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Cardiac CT scans 
All cardiac CT scans were performed using a 256-slice multi-detector row CT 
scanner (Brilliance iCT, Philips Healthcare, Best, The Netherlands). A total of 100 ml 
of intravenous contrast (Omnipaque, GE Healthcare, Princeton, NJ, USA) was 
injected (5 mL/s) via a power injector into the antecubital vein. Retrospectively ECG-
gated spiral scanning was performed with a single breath-hold technique and a delay 
of 10-12 seconds after contrast detection in the ascending aorta. Data acquisition 
parameters included a heart rate-dependent pitch of 0.2-0.45, a gantry rotation time 
of 270 ms, a tube voltage of 100 or 120 kVp depending on the patient’s body mass 
index and a tube current of 125-300 mA, depending upon the thoracic circumference.  
 
Computational modeling 
From the CT scans, three-dimensional computer models of the left heart were 
created using image dedicated segmentation techniques (Mimics software v18.0, 
Materialise, Leuven, Belgium) by FEops (Gent, Belgium). The output of this 
segmentation process was subsequently used to generate a finite element mesh of 
the complete mitral valve apparatus, including the calcified mitral valve annulus, the 
(calcified) leaflets and the chordae. Three types of chordae were modeled: marginal 
chords that connect to the free edge of the leaflets, strut chords inserting at the body 
of the anterior leaflet, and basal chords inserting at the body of the posterior leaflet. 
Varying mechanical properties were automatically assigned to different tissue 
regions. Following this, detailed computer models of the valve that accurately 
represented mechanical device behavior (e.g. braided wires, locking mechanism) 
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were virtually implanted in the patient-specific left heart models using finite element 
simulations. All simulations were performed using the Abaqus/Explicit v6.14 finite 
element solver (Dassault Systèmes, Paris, France). In each computer-simulated 
implantation, all steps of the clinical or in-vivo implantation (if performed) were 
respected consisting of valve size selection, and implantation position (Figs. 1-3, 
Movie clip 1). The simulation run-time was <3 hours using an Intel Core i7-6900K 
(3.2 GHz) processor. Since this was an exploratory study, for cases 1 and 2 the 
computer simulations were undertaken after the clinical procedure had been 
performed. For case 3, the computer simulation was performed prior to any clinical 
procedure and was used to determine anatomical suitability.  
 
Results 
Case 1  
A 65-year-old patient with the history of prior TAVR presented with increasing 
shortness of breath. The transthoracic echocardiogram (TTE) showed severe MR 
with a left ventricular ejection fraction of 65%. Subsequent cardiac CT revealed 
extensive MAC with dystrophic involvement of basal myocardial segment (Figure 1). 
The patient was considered to be too high-risk for surgical MVR (Society of Thoracic 
Surgeons [STS] risk score 18%). Following standard geometric sizing and planning 
with transesophageal echocardiography (TEE) and cardiac CT, a Lotus valve 
(Boston Scientific, Marlborough, MA, USA) was implanted in the mitral position. The 
procedure was uneventful and at 6-month follow-up there was no residual MR, 
device dislodgment or LVOTO. In this case, the computer simulation performed after 
the procedure was concordant with  the pre-implantation CT evaluation in predicting 
suitability for TMVR. 
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Case 2 
A 69-year-old man with a background history of atrial fibrillation, prior coronary artery 
bypass grafting and  TAVR presented with increasing shortness of breath. TEE 
demonstrated heavy calcification and restriction of the mitral leaflets giving rise to 
significant MS. Cardiac CT demonstrated the presence of circumferential MAC 
(Figure 2). The patient was considered to be at too high risk for surgical MVR (STS 
risk score 17%). Following cardiac CT planning, the patient underwent implantation 
of a  Lotus valve in the mitral position under direct TEE guidance. He subsequently 
developed acute pulmonary oedema secondary to malposition of the valve relative to 
the annulus which gave rise to severe paravalvular regurgitation. The valve was 
surgically explanted with further implantation of a Sapien 3 (Edwards Lifesciences 
Inc., Irvine, CA, USA) valve into a 34-mm memo 3D ring (MEMO 3D Sorin Group, 
Saliggia, Italy).  In this case, the computer simulation performed after the procedure 
demonstrated unsuitability for TMVR owing to non-conformity of the prosthetic valve 
to the mitral valve annulus, potential device instability and a high risk of significant 
paravalvular regurgitation (Figure 2, Video 1). This was concordant with the 
unfavorable clinical outcome experienced.  
 
Case 3 
An 87-year-old woman with a history of atrial fibrillation and chronic kidney disease 
presented with increasing dyspnea. A TTE demonstrated extensive MAC with severe 
MR and preserved systolic function. She was considered to be at high surgical risk 
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for MVR (STS risk score 23%). She subsequently underwent a cardiac CT scan 
which confirmed the presence of circumferential MAC, a small left ventricular cavity 
size and a basal septal bulge (Figure 3). This led to concerns relating to LVOTO with 
a TMVR with an aortic prosthesis. As a consequence, the cardiac CT scan was used 
for computer simulation to determine anatomical suitability prior to any device 
deployment. This confirmed that implantation of a transcatheter valve would result in 
a good seal with the annulus but irrespective of positioning (high, medium or low 
within the left atrium), significant LVOTO was likely to ensue. TMV  deployment of 
an aortic prosthesis in the mitral position was aborted. In this case, pre-implantation 
computer simulation was consistent with the standard geometric evaluation in 
predicting unsuitability for a TMVR. 
 
Discussion  
The main findings of the current study are that novel computational modeling 
techniques may be of value when applied to cardiac CT to aid patient selection and  
predicting patient outcomes following TMVR with aortic prostheses in patients with 
severe MAC. 
 
In patients with severe mitral valve disease, the presence of significant MAC requires 
specific surgical techniques to repair or replace the abnormal mitral valve. Despite 
this, reoperation and mortality rates remain high.6 Accordingly there has been 
considerable interest in the use of transcatheter therapies as an alternative to 
surgery. In the recently published Global Registry of TMVR with aortic prosthesis in 
patients with significant MAC, Guerrero et al reported the results of 64 patients from 
32 centers who underwent transcatheter valve implantation in the presence of 
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significant MAC.  Of these, 59.4% underwent implantation of a Sapien XT valve 
(Edwards Lifesciences Inc., Irvine, CA, USA), 28.1% of a Sapien 3 valve (Edwards 
Lifesciences Inc., Irvine, CA, USA), 7.8% of a Sapien valve (Edwards Lifesciences 
Inc., Irvine, CA, USA),  and 4.7% of an Inovare valve (Braile Biomedical, São José do 
Rio Preto, Brazil). Although there was an improvement in New York Heart 
Association functional class in 84% of patients, the reported 30-day all-cause 
mortality was 29.7%.5  Despite the procedures being conducted at specialized 
centers, there was a technical failure rate in 28% of patients. A second device 
implantation was required in 17.2%, LVOTO occurred in 9.3% of patients whilst there 
was device embolization in 6.3% and cardiac perforation in 3% of patients.5 
Experience continues to gather and successful deployment of both Lotus valves and 
Direct Flow valves (Direct Flow Medical, Santa Rosa, CA, USA) in the mitral valve 
position has also been achieved.2, 3 Ongoing studies such as the MITRAL trial 
(NCT02370511) which is designed to evaluate the safety and efficacy of Sapien XT 
(Edwards Lifesciences Inc., Irvine, CA, USA)  or Sapien 3 implantation in 90 
inoperable patients with MAC or with failed prosthetic valves will continue to inform 
the scientific community as to the merits of this approach.  
 
Irrespective of the TMVR device or the clinical indication it is clear that careful pre-
procedural imaging is vital. Detailed echocardiographic evaluation of the mitral valve 
is required along with ECG-gated contrast enhanced multiphase cardiac CT. 
Currently, the evaluation of CT datasets relies heavily on standard geometric 
measurements made by experienced practitioners of CT at specialized centers. With 
complication rates being high, there is good reason to suggest that this strategy may 
be imperfect in predicting the risk of LVOTO and significant paravalvular regurgitation 
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regarding device migration following deployment.7  From our experience, it is likely 
that these relate to:  1) an inability to predict how replacement transcatheter valves 
will conform to the mitral valve annulus in the presence of significant calcification, 2) 
how the calcification will behave under conditions of radial stress and 3) how the 
depth of implantation and aorto-mitral-annulus angulation influences the development 
of significant LVOTO.8  
 
As computational modeling gains more prominence in cardiac imaging, there is hope 
that some of these techniques may refine conventional methods for interpreting 
cardiac CT datasets and provide added value for patient care. The current report 
indicates one potential area where computational modeling for a novel therapy may 
be of clinical use in improving patient selection and patient outcomes.  
 
 
Conclusions 
The current report suggests that the application of computational modeling to cardiac 
CT datasets may have the potential to enhance standard evaluation techniques for 
complex mitral valve interventions. Further work is indicated to evaluate these 
techniques in a prospective manner and in larger patient cohorts.  
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Figure legends 
Figure 1 
Case 1: Pre-procedural CT and post-procedural computer simulations  
Panel A shows the short axis view of the mitral valve, the conventional CT sizing 
measurements and the degree of mitral valve calcification. Panel B shows the apical 
long axis view and the relationship of the mitral valve annulus to the left ventricular 
outflow tract.  The white line indicates the TAVR in situ and the white arrow the mitral 
valve annulus calcification. Panels C and D show the simulated transcatheter valve in 
situ from the left atrium and left ventricular perspectives. Panels E shows the 
predicted appearance of the left ventricular outflow tract following deployment and 
Panel F the three chamber view of the valve in the annulus to achieve the LVOT 
appearance in Panel E.  
Ao: aorta, CT: computed tomography, LA: lefit atrium, LV: left ventricle, LVOT: Left 
ventricle outflow tract, TAVR: trans catheter aortic valve. 
 
Figure 2 
Case 2: Pre-procedural CT and post-procedural computer simulations 
Panel A shows the short axis view of the mitral valve, the conventional CT sizing 
measurements and the degree of mitral valve calcification. Panel B shows the apical 
long axis view and the relationship of the mitral valve annulus to the left ventricular 
outflow tract.  The white arrow shows the mitral valve annulus calcification. Panels C 
and D show the simulated transcatheter valve in situ from the left atrium and left 
ventricular perspectives. Note was made of a large area of malapposition between 
the valve and the annulus as potential substrate for significant paravalvular 
regurgitation. Panels E shows the predicted appearance of the left ventricular outflow 
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tract following deployment and Panel F the three chamber view of the valve in the 
annulus to achieve the LVOT appearance in Panel E.  
Ao: aorta, CT: computed tomography, LA: lefit atrium, LV: left ventricle, LVOT: Left 
ventricle outflow tract. 
 
Figure 3 
Case 3: Pre-procedural CT and computer simulations 
Panel A shows the short axis view of the mitral valve, the conventional CT sizing 
measurements and the degree of mitral valve calcification. Panel B shows the apical 
long axis view and the relationship of the mitral valve annulus to the left ventricular 
outflow tract.  The white arrow shows the mitral valve annulus calcification. Panels C 
and D show the simulated transcatheter valve in situ from the left atrium and left 
ventricular perspectives. Panels E shows the predicted appearance of the left 
ventricular outflow tract following deployment and Panel F the three chamber view of 
the valve in the annulus to achieve the LVOT appearance in Panel E.  
Ao: aorta, CT: computed tomography, LA: lefit atrium, LV: left ventricle, LVOT: Left 
ventricle outflow tract. 
 
Video 1 
The computer simulation video shows malapposition of the prosthetic valve against 
the mitral valve annulus with potential for device dislodgment and paravalvular 
regurgitation. 
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